Research Purposes Only

• HGH C-Terminal Fragment: 16-amino acid sequence (FLRIVQCRSVEGSCGF), ≥98% purity
• β3-AR Pathway Modulation: DAG-PKC-HSL lipolytic cascade activation research
• Selective Lipolysis Studies: GHR-independent fat metabolism without IGF-1 effects

GHK-Cuis a research peptide composed of the tripeptide sequence Gly-His-Lys bound to copper(II) ions, forming a biologically active peptide–metal complex studied for its role in extracellular matrix modulation and cellular signaling. Preclinical research indicates that GHK-Cu regulates collagen production, gene expression, and enzymatic antioxidant pathways through copper-mediated redox mechanisms. It serves as a model compound for investigating peptide-driven tissue remodeling, metalloprotein r

GLOW Blend 50mg research peptide for laboratory studies. Pharmaceutical-grade cosmetic peptide blend for in-vitro research only. Not for human consumption.

Human Chorionic Gonadotropin (hCG) - LHCGR agonist activating cAMP/PKA signaling cascades. Heterodimeric glycoprotein hormone. Purity ≥95%. Research use only.

• Master Reproductive Regulator: C-terminal decapeptide (YNWNSFGLRF-NH2), ≥95% purity
• KISS1R/GPR54 Agonist: 8-fold higher receptor affinity than kisspeptin-54 (Ki = 0.042 nM)
• GnRH Pulse Generator: Most potent GnRH neuron stimulator, 4-minute human plasma half-life

• Advanced Quad-Peptide Research Formulation: BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg (80mg total), extends GLOW Blend with KPV for enhanced inflammation modulation
• Comprehensive Repair Cascade: BPC-157 (cytoprotection, VEGFR2 activation), TB-500 (cell migration, angiogenesis), GHK-Cu (collagen synthesis, 4,000+ gene modulation), KPV (NF-κB inhibition, anti-inflammatory signaling)
• KPV Anti-Inflammatory Mechanism: C-terminal tripeptide of α-MSH, NF-κB pathway inhibition, TNF-α/IL-1β/IL-6 suppression, NO melanotropic effects (lacks melanocortin core sequence required for MC1R activation)